Shin-wha Lee

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Gastric-type Histology Independently Predicts Poor Survival in Surgically-treated Cervical Adenocarcinoma.

Gastric-type Histology Independently Predicts Poor Survival in Surgically-treated Cervical Adenocarcinoma.

Journal: Anticancer research

Published: March 04, 2026

Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk human papillomavirus testing in cervical cancer screening.

Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk human papillomavirus testing in cervical cancer screening.

Journal: Obstetrics & gynecology science

Published: February 19, 2026

Neoadjuvant Paclitaxel-Carboplatin Chemotherapy Followed by Cesarean Radical Hysterectomy in Pregnant Patients With Cervical Cancer: Obstetric, Neonatal, and Surgical Outcomes.

Neoadjuvant Paclitaxel-Carboplatin Chemotherapy Followed by Cesarean Radical Hysterectomy in Pregnant Patients With Cervical Cancer: Obstetric, Neonatal, and Surgical Outcomes.

Journal: The journal of obstetrics and gynaecology research

Published: February 11, 2026

Clinical significance of circulating tumor DNA monitoring based on TP53 mutation in high-grade serous ovarian cancer patients.

Clinical significance of circulating tumor DNA monitoring based on TP53 mutation in high-grade serous ovarian cancer patients.

Journal: Translational cancer research

Published: January 30, 2026

Dual PARP/Tankyrase Inhibition Enhances Antitumor Efficacy in PTEN-Deficient Endometrial Cancer.

Dual PARP/Tankyrase Inhibition Enhances Antitumor Efficacy in PTEN-Deficient Endometrial Cancer.

Journal: Journal of cellular and molecular medicine

Published: January 05, 2026

Tumor-informed circulating tumor DNA detection for personalized monitoring of treatment response in epithelial ovarian cancer.

Tumor-informed circulating tumor DNA detection for personalized monitoring of treatment response in epithelial ovarian cancer.

Journal: Practical laboratory medicine

Published: March 19, 2025

Correction: Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis.

Correction: Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis.

Journal: PloS one

Published: January 03, 2025

Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines.

Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines.

Journal: Journal of gynecologic oncology

Published: December 14, 2024

Real-world efficacy and toxicity of olaparib maintenance therapy in Korean ovarian cancer patients with an exploratory analysis of BRCA mutations.

Real-world efficacy and toxicity of olaparib maintenance therapy in Korean ovarian cancer patients with an exploratory analysis of BRCA mutations.

Journal: Gynecologic oncology

Published: November 06, 2024

The 2nd Annual Meeting of the East Asian Gynecologic Oncology Trial Group (EAGOT).

The 2nd Annual Meeting of the East Asian Gynecologic Oncology Trial Group (EAGOT).

Journal: Journal of gynecologic oncology

Published: September 02, 2024

The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with bevacizumab in platinum-naïve primary stage IVB cervical cancer.

The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with bevacizumab in platinum-naïve primary stage IVB cervical cancer.

Journal: Taiwanese journal of obstetrics & gynecology

Published: July 30, 2024

Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis.

Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis.

Journal: Journal of gynecologic oncology

Published: July 24, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026